Mizuho Bank Ltd. Purchases Shares of 102,518 CME Group Inc. $CME

Mizuho Bank Ltd. bought a new stake in CME Group Inc. (NASDAQ:CME) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 102,518 shares of the financial services provider’s stock, valued at approximately $22,638,940. CME Group comprises 0.0% of Mizuho Bank Ltd.’s portfolio, making the stock its 6th biggest position.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Northwestern Mutual Investment Management Company LLC boosted its position in CME Group by 0.3% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after purchasing an additional 37 shares during the last quarter. Rehmann Capital Advisory Group boosted its holdings in shares of CME Group by 4.3% during the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after purchasing an additional 37 shares during the last quarter. Endowment Wealth Management Inc. grew its holdings in shares of CME Group by 4.4% in the fourth quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock worth $244,000 after purchasing an additional 38 shares during the last quarter. NBT Bank N A NY increased its position in CME Group by 2.3% during the 1st quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock valued at $492,000 after buying an additional 38 shares in the last quarter. Finally, Resonant Capital Advisors LLC increased its holdings in CME Group by 3.8% in the first quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider’s stock valued at $317,000 after buying an additional 39 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Price Performance

CME traded up $4.22 during trading on Friday, reaching $285.16. The company’s stock had a trading volume of 971,534 shares, compared to its average volume of 2,633,935. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a fifty day simple moving average of $253.01 and a two-hundred day simple moving average of $279.09. The company has a market cap of $102.54 billion, a price-to-earnings ratio of 24.19, a PEG ratio of 3.34 and a beta of 0.23.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, beating the consensus estimate of $2.91 by $0.08. The business had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company’s quarterly revenue was up .8% compared to the same quarter last year. During the same period last year, the firm earned $2.96 EPS. As a group, analysts anticipate that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 44.11%.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on CME. Barclays reduced their price objective on CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research note on Thursday, July 9th. UBS Group decreased their price target on CME Group from $310.00 to $260.00 and set a “buy” rating for the company in a research note on Monday, July 6th. Wall Street Zen lowered CME Group from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 1st. JPMorgan Chase & Co. boosted their target price on CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a report on Thursday, July 23rd. Finally, Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and increased their target price for the company from $316.00 to $323.00 in a research report on Thursday, June 11th. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $288.56.

Insider Activity

In other news, Director William R. Shepard acquired 325 shares of CME Group stock in a transaction on Thursday, June 25th. The shares were purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the purchase, the director directly owned 260,442 shares of the company’s stock, valued at approximately $60,050,111.94. This represents a 0.12% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.30% of the stock is currently owned by corporate insiders.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.